GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DXCM · Dec 31, 2020

DEXCOM INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001093557-21-000024General Corporate
Capex intensity38thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

10.33% · OPTIONAL · VALID

Operating cash generation75thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

24.68% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

30.54% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure25thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

12.18% · OPTIONAL · VALID

Gross margin88thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.gross_margin

66.44% · CORE · VALID

Operating margin88thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

15.54% · CORE · VALID

R&D intensity63thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

18.68% · OPTIONAL · VALID

SBC intensity38thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

6.20% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History21 statesSelf-history eligible
Mar 31, 20190/7 normalizedLevel 3Jun 30, 20190/7 normalizedLevel 3Sep 30, 20190/7 normalizedLevel 3Dec 31, 20190/8 normalizedLevel 3Mar 31, 20200/8 normalizedLevel 3Jun 30, 20200/8 normalizedLevel 3Sep 30, 20200/8 normalizedLevel 3Dec 31, 20207/8 normalizedLevel 3Mar 31, 20217/8 normalizedLevel 3Jun 30, 20217/8 normalizedLevel 3Sep 30, 20217/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Sep 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Capex Intensity Increased
Previous
9.46%
Current
10.33%
Delta
0.87%
Cash Generation Decreased
Previous
29.47%
Current
24.68%
Delta
-4.78%
Growth Increased
Previous
26.39%
Current
30.54%
Delta
4.14%
Inventory Pressure Decreased
Previous
40.07%
Current
12.18%
Delta
-27.89%
Margin Decreased
Previous
67.96%
Current
66.44%
Delta
-1.52%
Profitability Decreased
Previous
18.79%
Current
15.54%
Delta
-3.24%
R And D Intensity Increased
Previous
17.51%
Current
18.68%
Delta
1.17%
Sbc Intensity Increased
Previous
6.13%
Current
6.20%
Delta
0.07%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · DXCM Fundamental State →Has State · DEXCOM INC →Transitioned To · DXCM CASH_GENERATION_DECREASED →Transitioned To · DXCM INVENTORY_PRESSURE_DECREASED →Transitioned To · DXCM MARGIN_DECREASED →Transitioned To · DXCM Fundamental State →Transitioned To · DXCM CAPEX_INTENSITY_INCREASED →Transitioned To · DXCM GROWTH_INCREASED →Transitioned To · DXCM PROFITABILITY_DECREASED →Transitioned To · DXCM R_AND_D_INTENSITY_INCREASED →Transitioned To · DXCM SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.